NIT2_RAT
ID NIT2_RAT Reviewed; 276 AA.
AC Q497B0;
DT 26-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT 13-SEP-2005, sequence version 1.
DT 03-AUG-2022, entry version 97.
DE RecName: Full=Omega-amidase NIT2;
DE EC=3.5.1.3 {ECO:0000269|PubMed:19595734};
DE AltName: Full=Nitrilase homolog 2;
GN Name=Nit2;
OS Rattus norvegicus (Rat).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC Murinae; Rattus.
OX NCBI_TaxID=10116;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Prostate;
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA project:
RT the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
RN [2]
RP FUNCTION.
RX PubMed=19464248; DOI=10.1016/j.ab.2009.05.025;
RA Krasnikov B.F., Nostramo R., Pinto J.T., Cooper A.J.L.;
RT "Assay and purification of omega-amidase/Nit2, a ubiquitously expressed
RT putative tumor suppressor, that catalyzes the deamidation of the alpha-keto
RT acid analogues of glutamine and asparagine.";
RL Anal. Biochem. 391:144-150(2009).
RN [3]
RP FUNCTION, SUBUNIT, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX PubMed=19595734; DOI=10.1016/j.biochi.2009.07.003;
RA Krasnikov B.F., Chien C.-H., Nostramo R., Pinto J.T., Nieves E.,
RA Callaway M., Sun J., Huebner K., Cooper A.J.L.;
RT "Identification of the putative tumor suppressor Nit2 as omega-amidase, an
RT enzyme metabolically linked to glutamine and asparagine transamination.";
RL Biochimie 91:1072-1080(2009).
CC -!- FUNCTION: Has omega-amidase activity. The role of omega-amidase is to
CC remove potentially toxic intermediates by converting 2-oxoglutaramate
CC and 2-oxosuccinamate to biologically useful 2-oxoglutarate and
CC oxaloacetate, respectively. {ECO:0000269|PubMed:19464248,
CC ECO:0000269|PubMed:19595734}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=a monoamide of a dicarboxylate + H2O = a dicarboxylate +
CC NH4(+); Xref=Rhea:RHEA:11716, ChEBI:CHEBI:15377, ChEBI:CHEBI:28938,
CC ChEBI:CHEBI:28965, ChEBI:CHEBI:77450; EC=3.5.1.3;
CC Evidence={ECO:0000269|PubMed:19595734};
CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11717;
CC Evidence={ECO:0000269|PubMed:19595734};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=2-oxoglutaramate + H2O = 2-oxoglutarate + NH4(+);
CC Xref=Rhea:RHEA:32963, ChEBI:CHEBI:15377, ChEBI:CHEBI:16769,
CC ChEBI:CHEBI:16810, ChEBI:CHEBI:28938; EC=3.5.1.3;
CC Evidence={ECO:0000269|PubMed:19595734};
CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:32964;
CC Evidence={ECO:0000269|PubMed:19595734};
CC -!- CATALYTIC ACTIVITY:
CC Reaction=2-oxosuccinamate + H2O = NH4(+) + oxaloacetate;
CC Xref=Rhea:RHEA:59412, ChEBI:CHEBI:15377, ChEBI:CHEBI:16452,
CC ChEBI:CHEBI:28938, ChEBI:CHEBI:57735; EC=3.5.1.3;
CC Evidence={ECO:0000269|PubMed:19464248};
CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:59413;
CC Evidence={ECO:0000269|PubMed:19464248};
CC -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC Kinetic parameters:
CC KM=0.0054 mM for 2-oxoglutaramate (open-chain form)
CC {ECO:0000269|PubMed:19595734};
CC Vmax=20.6 umol/min/mg enzyme with 2-oxoglutaramate as substrate
CC {ECO:0000269|PubMed:19595734};
CC Note=In solution, 2-oxoglutaramate is in equilibrium with a cyclic
CC form (2-hydroxy-5-oxoproline), and at pH 8.0 or above, the rate of
CC ring opening is no longer limiting for the omega-amidase reaction.;
CC -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:19595734}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9NQR4}.
CC -!- SIMILARITY: Belongs to the carbon-nitrogen hydrolase superfamily.
CC NIT1/NIT2 family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; BC100637; AAI00638.1; -; mRNA.
DR RefSeq; NP_001029298.1; NM_001034126.1.
DR AlphaFoldDB; Q497B0; -.
DR SMR; Q497B0; -.
DR BioGRID; 252479; 1.
DR STRING; 10116.ENSRNOP00000034144; -.
DR iPTMnet; Q497B0; -.
DR PhosphoSitePlus; Q497B0; -.
DR jPOST; Q497B0; -.
DR PaxDb; Q497B0; -.
DR PRIDE; Q497B0; -.
DR GeneID; 288174; -.
DR KEGG; rno:288174; -.
DR UCSC; RGD:1310494; rat.
DR CTD; 56954; -.
DR RGD; 1310494; Nit2.
DR VEuPathDB; HostDB:ENSRNOG00000027797; -.
DR eggNOG; KOG0806; Eukaryota.
DR HOGENOM; CLU_030130_1_0_1; -.
DR InParanoid; Q497B0; -.
DR OMA; GNTYRES; -.
DR OrthoDB; 1154369at2759; -.
DR PhylomeDB; Q497B0; -.
DR TreeFam; TF300747; -.
DR Reactome; R-RNO-6798695; Neutrophil degranulation.
DR PRO; PR:Q497B0; -.
DR Proteomes; UP000002494; Chromosome 11.
DR Bgee; ENSRNOG00000027797; Expressed in kidney and 19 other tissues.
DR Genevisible; Q497B0; RN.
DR GO; GO:0005813; C:centrosome; IEA:Ensembl.
DR GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR GO; GO:0106008; F:2-oxoglutaramate amidase activity; IEA:RHEA.
DR GO; GO:0050152; F:omega-amidase activity; ISO:RGD.
DR GO; GO:0006528; P:asparagine metabolic process; ISO:RGD.
DR GO; GO:0006541; P:glutamine metabolic process; ISO:RGD.
DR GO; GO:0006107; P:oxaloacetate metabolic process; ISO:RGD.
DR CDD; cd07572; nit; 1.
DR Gene3D; 3.60.110.10; -; 1.
DR InterPro; IPR003010; C-N_Hydrolase.
DR InterPro; IPR036526; C-N_Hydrolase_sf.
DR InterPro; IPR045254; Nit1/2_C-N_Hydrolase.
DR Pfam; PF00795; CN_hydrolase; 1.
DR SUPFAM; SSF56317; SSF56317; 1.
DR PROSITE; PS50263; CN_HYDROLASE; 1.
PE 1: Evidence at protein level;
KW Acetylation; Cytoplasm; Hydrolase; Phosphoprotein; Reference proteome.
FT CHAIN 1..276
FT /note="Omega-amidase NIT2"
FT /id="PRO_0000320256"
FT DOMAIN 4..248
FT /note="CN hydrolase"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00054"
FT ACT_SITE 43
FT /note="Proton acceptor"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00054"
FT ACT_SITE 112
FT /note="Proton donor"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00054"
FT ACT_SITE 153
FT /note="Nucleophile"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00054"
FT MOD_RES 26
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:Q9NQR4"
FT MOD_RES 68
FT /note="N6-acetyllysine; alternate"
FT /evidence="ECO:0000250|UniProtKB:Q9JHW2"
FT MOD_RES 68
FT /note="N6-succinyllysine; alternate"
FT /evidence="ECO:0000250|UniProtKB:Q9JHW2"
FT MOD_RES 123
FT /note="N6-succinyllysine"
FT /evidence="ECO:0000250|UniProtKB:Q9JHW2"
FT MOD_RES 130
FT /note="N6-succinyllysine"
FT /evidence="ECO:0000250|UniProtKB:Q9JHW2"
SQ SEQUENCE 276 AA; 30701 MW; 38C64D674B171EF3 CRC64;
MSTFRLALIQ LQVSSIKSDN ITRACSLVRE AAKQGANIVS LPECFNSPYG TNYFPEYAEK
IPGESTKKLS EVAKENSIYL IGGSIPEEDD GKLYNTCAVF GPDGNLLVKH RKIHLFDIDV
PGKITFQESK TLSPGDSFST FDTPYCRVGL GICYDMRFAE LAQIYARRGC QLLVYPGAFN
MTTGPAHWEL LQRARAVDNQ VYVATASPAR DEKASYVAWG HSTVVDPWGQ VLTKAGTEET
ILYSDIDLKK LSEIRQQIPI LKQKRADLYS VESKKP